Patient Recruitment Applications & Studies
-
Recruitment Improved With Home Trial Support
3/28/2023
Discover how a complex oncology study with alternating visits between hospital, outpatient, and home was able to overcome enrollment issues.
-
NeuraLace Doubles Clinical Trial Enrollment & Improves Participant Compliance With EDC & ePRO
3/20/2023
Find out how one company dedicated to producing innovative non-invasive chronic pain therapies was able to engage its patients in new ways.
-
Supporting Enrollment Of A Phase 2 Cervical Cancer Study During A Pandemic
10/13/2022
The developer of an investigative medicinal product (IMP) for advanced, recurrent, non-resectable cervical cancer engaged Premier Research to assist with screening and enrollment in a Phase 2 study in Europe. Find out the results of this partnership.
-
Demonstrating The Impact Of The Longboat Portal On Recruitment Success
10/13/2022
A top-30 pharmaceutical company was conducting two phase 3, multicentre, randomized, double-blind studies to evaluate the safety and efficacy of a treatment for a serious dermatological condition. So how did the sites involved manage such significant and prolonged engagement?
-
How A Remote ePRO Solution Helped Reduce Patient Burden
9/19/2022
Discover how transitioning multiple studies from on-site to at-home assessments improved patient retention and recruitment for a global neurology program.
-
How A Top 3 Global CRO Reduced The Impact Of CRA Hiring And Retention Challenges
8/22/2022
Learn how a top 3 global CRO implemented technology to remotely connect with their research sites and can now monitor up to 50 sites per week, compared to the former average of two on-site monitoring visits per week.
-
Patient Diversity Case Study: RWD Solutions
7/18/2022
See how by leveraging medical claims and diversity data, this clinical trial sponsor was able to identify relevant patients meeting the trial’s I/E criteria, broken out by race and gender.
-
How We Achieved 100% Recruitment 7 Months Ahead Of Schedule
6/14/2022
Uncover how a mid-sized European contract research organization successfully completed a Phase 3 lung cancer clinical study jointly with a global CRO.
-
Recruiting For Rezolute's Pediatric Congenital Hyperinsulinism Trial
6/13/2022
Rezolute faced a challenging task— to recruit pediatric patients for a clinical trial of an ultra-rare disease. In addition, Rezolute wanted to increase global awareness of the trial. Learn how a three-pronged approach was used to address these challenges and achieve randomizations.
-
Predicting Dropout Rates In DCTs
6/2/2022
In this case study, discover the complexity that decentralized clinical trials (DCTs) may add to patient enrollment and retention due to the lack of interaction between patient and trial personnel.